Related Experiment Videos

Pulmonary Rhizopus infection in a diabetic renal transplant recipient

A Demirag1, E A Elkhammas, M L Henry

  • 1The Ohio State University College of Medicine, Department of Surgery, Columbus 43210, USA.

Clinical Transplantation
|February 29, 2000
PubMed

Insights

Mucormycosis is a rare but deadly fungal infection in kidney transplant patients. Successful treatment involves Amphotericin B and surgery, preserving allograft function.

Area of Science:

  • Medical Mycology
  • Transplant Infectious Diseases
  • Nephrology

Background:

  • Infectious complications are a leading cause of morbidity and mortality post-renal transplantation.
  • Mucormycosis, a rare fungal infection, carries an extremely high mortality rate in renal transplant recipients.
  • Risk factors include immunosuppression, neutropenia, and diabetes.

Observation:

  • A case of invasive cavitary Rhizopus lung infection occurred 2 months post-renal transplantation.
  • The patient presented with symptoms suggestive of a serious fungal infection.
  • The fungus exhibits a propensity for vascular invasion, leading to dissemination.

Findings:

  • Successful treatment was achieved with Amphotericin B and surgical resection of lung lesions.
  • Allograft function was preserved throughout the treatment course.
  • Early and invasive diagnostic work-up is crucial for timely intervention.

Implications:

  • Increased incidence of mucormycosis is anticipated in transplant populations due to intensified immunosuppression.
  • Amphotericin B and surgical resection are the primary therapeutic strategies.
  • Prompt diagnosis and management are vital for improving outcomes in transplant recipients with mucormycosis.

Related Concept Videos